Article abstract-Dopa-responsive dystonia (DRD) is an autosomal dominant disorder typically presenting as dystonia with diurnal variability. Described is an 8-year-old boy who had had waddling gait, generalized hypotonia, and proximal weakness since early childhood. He responded well to low-dose L-dopa. He had a point mutation of the GTP cyclohydrolase I gene. The patient's father and sister had the same mutation but did not have proximal weakness. GTP cyclohydrolase I deficiency can present with hypotonia and weakness. NEUROLOGY 2001;57:1121-1124 Chi-Keung Kong, MBChB, FHKAM(Paed); Chun-Hung Ko, MBChB, FHKAM(Paed); Sui Fan Tong, MSc; and Ching-Wan Lam, MBChB, PhD Dopa-responsive dystonia (DRD) usually presents with diurnal dystonia. We report a boy who was first suspected to have myopathy but was subsequently diagnosed with DRD. His symptoms responded to L-dopa/carbidopa. The clinical suspicion was confirmed by identifying a point mutation at exon 5 of the GTP cyclohydrolase I gene.
Case report. The patient was an 8-year-old boy with normal birth history. He had been noted to be floppy since early infancy. Gross motor development was delayed. Head control was poor before 1 year of age. He attained unsupported sitting by 8 months and independent standing by 16 months of age. He started walking at 21 months. He was clumsy. At the age of 8, he still had difficulty in buttoning and tying shoelaces. Cognitive development, social interaction, and bladder control were normal. He had average school performance. Although there was normal comprehension of speech, his expressive speech was mildly slurred. He had no problem with feeding. Since the age of 4, he was noticed to have frequent falls and fatigability. He could walk for only about 10 minutes, with worsening of the fatigability in the evening. He sometimes had some hand tremors in the afternoon. By the age of 7, he was noticed to be increasingly dysphonic toward the end of the day. There were episodic neck and back cramps in the afternoon that might last for a few hours. On examination, he was a happy child with a paucity of facial expression. He was hypotonic, but there was mild tightness in both Achilles tendons. He gave a general impression of being slow and weak in movement. He was found to have winging of the scapula when he used his left hand to push against resistance. Shoulder abduction, neck flexion, and hip abduction were also found to be weak, with power about grade 4 over 5. He had difficulty sitting up from a lying position. He could not stand for more than a few seconds on either leg. Pelvic drop on standing with one leg (Trendelenburg sign) was noted. He had asymmetric waddling gait with more prominent body side swinging while on his right foot ( figure 1A ). When he was asked to stand up from a lying position, he had to spread out and use his right hand on the floor to push himself to sit up first. He flexed his waist and knees. He put his right foot on the floor and used that knee as a support for his right hand to push himself up (figure 2A). Though he did not have to climb up his legs as children with Gowers sign do, by this maneuver he did shift some of his body weight to his leg indirectly on standing up. Deep tendon and plantar reflexes were normal.
The patient was suspected to have a myopathy. Extensive investigations including complete blood count, renal and liver function tests, random serum glucose, creatine kinase, metabolic screening, lactate, pyruvate, and carnitine levels were normal. Nerve conduction and electromyographic studies revealed no evidence of neuropathy or myopathy. CT and MRI of the brain were normal. MRI of trunk and limb muscles for screening of myopathy was normal. Light microscopy examination of his muscle biopsy did not reveal any abnormality. Subsarcolemmal mitochondrial aggregation with glycogen accumulation was detected on electron microscopy, but the activities of all the respiratory chain enzymes were normal.
The boy had a sister who was 2 years younger. She was well until age 5 when she gradually developed equinovarus and pes cavus deformity of the right foot. She was also hypotonic. Extensive investigations were also performed, with no definite abnormalities identified.
Eventually, their symptoms were noted to be progressively worse toward evening, and the possibility of DRD was considered. A small dose of L-dopa/carbidopa (SINEMET 25/100; Merck Sharp & Dohme International, Rahway, NJ) was prescribed as a diagnostic and therapeutic trial. Both patients showed excellent response to the treatment.
Two weeks after being started on L-dopa 25 mg/carbidopa 6.25 mg (quarter tablet of SINEMET 25/100) twice daily, the boy showed significant improvement in his gait and speech. His handwriting improved. No waddling was noted on walking (figure 1B). He could stand up from lying much more easily (figure 2B). Scapular winging also disappeared. The SINEMET 25/100 (quarter tablet) nevertheless was further increased to thrice daily for better control of neck cramps in the afternoon. Interestingly, the patient and his sister remained hypotonic even after treatment.
Molecular genetic analysis showed that both sibs and their father were heterozygous for a previously described GTP cyclohydrolase I gene mutation: Gly203Arg. 1 This re-sult and the excellent and sustained response to Sinemet confirmed the diagnosis of DRD in both sibs.
Discussion. DRD is a movement disorder characterized by diurnal fluctuation of tone. 2 The onset is usually in childhood, with dystonia most frequently starting in one or both legs. In some patients, the disease may simulate nonprogressive spastic paraparesis or spastic cerebral palsy with brisk tendon reflexes. 3, 4 Various presentations have been seen in DRD. These include cerebral palsy, generalized idiopathic torsional dystonia, focal dystonia, and parkinsonism. 5 To our knowledge, DRD presenting with generalized hypotonia and proximal muscle weakness is probably rather rare or unnoticed before. There was one boy reported to have weakness of his legs toward evening, but in this patient, the muscle tone was increased instead of being decreased as in our patient. 6 He had generalized dystonia. Muscle power was grade 4 over 5 in both upper and lower limbs. Hence, this boy appeared to have combined dystonia and weakness. In our patient, the weakness and clumsiness dominated the clinical picture. On detailed examination, our patient was hypotonic with mild but definite weakness on neck flexion, shoulder abduction, and hip abduction. In addition, pelvic drop on standing with either leg, waddling gait, and difficulty on sitting up from the lying position and standing up from the sitting position are all suggestive of proximal and truncal muscle weakness. His apparent clumsiness probably was the result of bradykinesia and weakness. The typical feature of diurnal dystonia (neck and back cramps that worsened toward evening) was not apparent until late in the clinical course. The patient was subjected to unnecessary invasive procedures (such as muscle biopsy) because of the atypical presentation and the delay in diagnosis.
Intrafamilial expression variability is demonstrated in this report, with the same genotype expressing as asymptomatic, typical DRD, and proximal weakness in different family members. This is in contrast to the previous suggestion of homogeneity in the clinical presentations of patients with mutations at different sites of the GTP cyclohydrolase I gene. 7 The underlying mechanism of the phenotypic heterogeneity in our family remains obscure. Genetic and environmental factors related to gender may modulate the outcome of the GTP cyclohydrolase I mutations in DRD. 8 DRD is an interesting disease that can have different combinations of extrapyramidal and pyramidal signs. This case alerts us to the possibility that hypotonia and weakness may be part of the clinical features of patients with DRD and may even dominate the clinical picture and lead to delay in diagnosis and treatment. Now that we have confirmed a DRD diagnosis with this presentation, we will consider the diagnosis of DRD in other patients with unexplained hypotonia and weakness. By extending the range of patients with a molecular genetic diagnosis of DRD, we will be able to progress further in understanding this complex and challenging condition. Values are given as percentages unless otherwise indicated.
